R. Kriel

SARS-CoV-2 viral replication persists in the human lung for several weeks after onset of symptomatic severe COVID-19 and is associated with attenuated pulmonary immunity and variant-specific clinical sequalae

S. Madhi, A. Sigal, C. Williamson, 2023, medRxiv.

Plasmablastic lymphomas show restricted EBV latency profile and MYC gene aberrations

D. Govender, A. Ramburan, R. Kriel, 2021, Leukemia & lymphoma.

SARS-CoV-2 Viral Replication Persists in the Human Lung for Several Weeks after Symptom Onset

S. Madhi, A. Sigal, K. Dheda, 2024, American journal of respiratory and critical care medicine.